{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T06:29:30Z","timestamp":1781332170742,"version":"3.54.1"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100024506","name":"Faculty of Medical Sciences, Tarbiat Modares University","doi-asserted-by":"publisher","award":["9620332005"],"award-info":[{"award-number":["9620332005"]}],"id":[{"id":"10.13039\/501100024506","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024506","name":"Faculty of Medical Sciences, Tarbiat Modares University","doi-asserted-by":"publisher","award":["9620332005"],"award-info":[{"award-number":["9620332005"]}],"id":[{"id":"10.13039\/501100024506","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024506","name":"Faculty of Medical Sciences, Tarbiat Modares University","doi-asserted-by":"publisher","award":["9620332005"],"award-info":[{"award-number":["9620332005"]}],"id":[{"id":"10.13039\/501100024506","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s12035-025-04903-8","type":"journal-article","created":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T03:33:47Z","timestamp":1743996827000},"page":"10182-10200","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Evaluating the Protective Effects of Silymarin Along with a Cholesterol-Supplemented Diet Against Demyelination in an EAE Mouse Model of Multiple Sclerosis: Lipidomic and Inflammatory Aspects"],"prefix":"10.1007","volume":"62","author":[{"given":"Parvin","family":"Mosaddeghi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Alireza","family":"Mesbah-Namin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Javan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,7]]},"reference":[{"issue":"3","key":"4903_CR1","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1006\/nbdi.1999.0239","volume":"6","author":"P Conlon","year":"1999","unstructured":"Conlon P, Oksenberg JR, Zhang J, Steinman L (1999) The immunobiology of multiple sclerosis: an autoimmune disease of the central nervous system. Neurobiol Dis 6(3):149\u2013166","journal-title":"Neurobiol Dis"},{"issue":"1\u20132","key":"4903_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jneuroim.2011.03.003","volume":"234","author":"JM Greer","year":"2011","unstructured":"Greer JM, McCombe PA (2011) Role of gender in multiple sclerosis: clinical effects and potential molecular mechanisms. J Neuroimmunol 234(1\u20132):7\u201318","journal-title":"J Neuroimmunol"},{"issue":"8","key":"4903_CR3","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1093\/brain\/awl075","volume":"129","author":"R Gold","year":"2006","unstructured":"Gold R, Linington C, Lassmann H (2006) Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 129(8):1953\u20131971","journal-title":"Brain"},{"issue":"2","key":"4903_CR4","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1034\/j.1600-0404.2002.01334.x","volume":"106","author":"F Giubilei","year":"2002","unstructured":"Giubilei F, Antonini G, Di Legge S, Sormani M, Pantano P, Antonini R, Sepe-Monti M, Caramia F et al (2002) Blood cholesterol and MRI activity in first clinical episode suggestive of multiple sclerosis. Acta Neurol Scand 106(2):109\u2013112","journal-title":"Acta Neurol Scand"},{"key":"4903_CR5","doi-asserted-by":"publisher","first-page":"105889","DOI":"10.1016\/j.nbd.2022.105889","volume":"174","author":"M-E Evangelopoulos","year":"2022","unstructured":"Evangelopoulos M-E, Koutsis G, Boufidou F, Markianos M (2022) Cholesterol levels in plasma and cerebrospinal fluid in patients with clinically isolated syndrome and relapsing-remitting multiple sclerosis. Neurobiol Dis 174:105889","journal-title":"Neurobiol Dis"},{"key":"4903_CR6","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.msard.2015.10.005","volume":"5","author":"S Zhornitsky","year":"2016","unstructured":"Zhornitsky S, McKay KA, Metz LM, Teunissen CE, Rangachari M (2016) Cholesterol and markers of cholesterol turnover in multiple sclerosis: relationship with disease outcomes. Mult Scler Relat Disord 5:53\u201365","journal-title":"Mult Scler Relat Disord"},{"issue":"4","key":"4903_CR7","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.msard.2014.01.004","volume":"3","author":"S Vuletic","year":"2014","unstructured":"Vuletic S, Kennedy H, Albers JJ, Killestein J, Vrenken H, L\u00fctjohann D, Teunissen CE (2014) Cerebrospinal fluid apolipoprotein E and phospholipid transfer protein activity are reduced in multiple sclerosis; relationships with the brain MRI and CSF lipid variables. Mult Scler Relat Disord 3(4):533\u2013541","journal-title":"Mult Scler Relat Disord"},{"issue":"16","key":"4903_CR8","doi-asserted-by":"publisher","first-page":"8370","DOI":"10.3390\/ijms22168370","volume":"22","author":"R Balasa","year":"2021","unstructured":"Balasa R, Barcutean L, Mosora O, Manu D (2021) Reviewing the significance of blood\u2013brain barrier disruption in multiple sclerosis pathology and treatment. Int J Mol Sci 22(16):8370","journal-title":"Int J Mol Sci"},{"issue":"4","key":"4903_CR9","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1086\/662453","volume":"86","author":"AP Corthals","year":"2011","unstructured":"Corthals AP (2011) Multiple sclerosis is not a disease of the immune system. Q Rev Biol 86(4):287\u2013321","journal-title":"Q Rev Biol"},{"key":"4903_CR10","doi-asserted-by":"publisher","unstructured":"Sena A, Capela C, N\u00f3brega C, F\u00e9rret-Sena V, Campos E, Pedrosa R (2012) Plasma lipoproteins in brain inflammatory and neurodegenerative diseases. In: Lipoproteins-Role in Health and Diseases. IntechOpen. https:\/\/doi.org\/10.5772\/51268","DOI":"10.5772\/51268"},{"key":"4903_CR11","first-page":"1083","volume":"8","author":"G Saher","year":"1851","unstructured":"Saher G (1851) Stumpf SK (2015) Cholesterol in myelin biogenesis and hypomyelinating disorders. Biochim Biophys Acta (BBA) - Mol Cell Biol Lipids 8:1083\u20131094","journal-title":"Biochim Biophys Acta (BBA) - Mol Cell Biol Lipids"},{"issue":"4","key":"4903_CR12","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.plipres.2011.06.002","volume":"50","author":"FW Pfrieger","year":"2011","unstructured":"Pfrieger FW, Ungerer N (2011) Cholesterol metabolism in neurons and astrocytes. Prog Lipid Res 50(4):357\u2013371","journal-title":"Prog Lipid Res"},{"issue":"3","key":"4903_CR13","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1093\/cvr\/cvu148","volume":"103","author":"C Vitali","year":"2014","unstructured":"Vitali C, Wellington CL, Calabresi L (2014) HDL and cholesterol handling in the brain. Cardiovasc Res 103(3):405\u2013413","journal-title":"Cardiovasc Res"},{"key":"4903_CR14","first-page":"806","volume":"8","author":"JE Vance","year":"1801","unstructured":"Vance JE (1801) Hayashi H (2010) Formation and function of apolipoprotein E-containing lipoproteins in the nervous system. Biochim Biophys Acta (BBA) - Mol Cell Biol Lipids 8:806\u2013818","journal-title":"Biochim Biophys Acta (BBA) - Mol Cell Biol Lipids"},{"issue":"5","key":"4903_CR15","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1111\/j.1471-4159.2007.05099.x","volume":"104","author":"WS Kim","year":"2008","unstructured":"Kim WS, Weickert CS, Garner B (2008) Role of ATP-binding cassette transporters in brain lipid transport and neurological disease. J Neurochem 104(5):1145\u20131166","journal-title":"J Neurochem"},{"issue":"2","key":"4903_CR16","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0304-3940(94)90519-3","volume":"180","author":"TG Jensen","year":"1994","unstructured":"Jensen TG, Roses AD, J\u00f8rgensen AL (1994) Apolipoprotein E uptake and degradation via chloroquine-sensitive pathway in cultivated monkey cells overexpressing low density lipoprotein receptor. Neurosci Lett 180(2):193\u2013196","journal-title":"Neurosci Lett"},{"key":"4903_CR17","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.bbalip.2012.09.007","volume":"2","author":"J Chen","year":"2013","unstructured":"Chen J, Zhang X, Kusumo H, Costa LG, Guizzetti M (2013) Cholesterol efflux is differentially regulated in neurons and astrocytes: implications for brain cholesterol homeostasis. Biochim Biophys Acta Mol Cell Biol Lipids 2:263\u2013275","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"issue":"1","key":"4903_CR18","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/jnr.20607","volume":"82","author":"A Iwata","year":"2005","unstructured":"Iwata A, Browne KD, Chen XH, Yuguchi T, Smith DH (2005) Traumatic brain injury induces biphasic upregulation of ApoE and ApoJ protein in rats. J Neurosci Res 82(1):103\u2013114","journal-title":"J Neurosci Res"},{"issue":"10","key":"4903_CR19","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1194\/jlr.M060970","volume":"56","author":"K Fellows","year":"2015","unstructured":"Fellows K, Uher T, Browne RW, Weinstock-Guttman B, Horakova D, Posova H, Vaneckova M, Seidl Z et al (2015) Protective associations of HDL with blood-brain barrier injury in multiple sclerosis patients. J Lipid Res 56(10):2010\u20132018","journal-title":"J Lipid Res"},{"issue":"4","key":"4903_CR20","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/7766","volume":"21","author":"M Jaye","year":"1999","unstructured":"Jaye M, Lynch KJ, Krawiec J, Marchadier D, Maugeais C, Doan K, South V, Amin D et al (1999) A novel endothelial-derived lipase that modulates HDL metabolism. Nat Genet 21(4):424\u2013428","journal-title":"Nat Genet"},{"issue":"12","key":"4903_CR21","doi-asserted-by":"publisher","first-page":"3740","DOI":"10.3390\/ijms19123740","volume":"19","author":"L Biswas","year":"2018","unstructured":"Biswas L, Farhan F, Reilly J, Bartholomew C, Shu X (2018) TSPO ligands promote cholesterol efflux and suppress oxidative stress and inflammation in choroidal endothelial cells. Int J Mol Sci 19(12):3740","journal-title":"Int J Mol Sci"},{"issue":"3","key":"4903_CR22","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1007\/s12035-022-02737-2","volume":"59","author":"C Tremolanti","year":"2022","unstructured":"Tremolanti C, Cavallini C, Meyer L, Klein C, Da Pozzo E, Costa B, Germelli L, Taliani S et al (2022) Translocator protein ligand PIGA1138 reduces disease symptoms and severity in experimental autoimmune encephalomyelitis model of primary progressive multiple sclerosis. Mol Neurobiol 59(3):1744\u20131765","journal-title":"Mol Neurobiol"},{"issue":"9","key":"4903_CR23","doi-asserted-by":"publisher","first-page":"110423","DOI":"10.1016\/j.celrep.2022.110423","volume":"38","author":"L Khandker","year":"2022","unstructured":"Khandker L, Jeffries MA, Chang Y-J, Mather ML, Evangelou AV, Bourne JN, Tafreshi AK, Ornelas IM, Bozdagi-Gunal O, Macklin WB (2022) Cholesterol biosynthesis defines oligodendrocyte precursor heterogeneity between brain and spinal cord. Cell Rep 38(9):110423","journal-title":"Cell Rep"},{"key":"4903_CR24","doi-asserted-by":"publisher","first-page":"1024058","DOI":"10.3389\/fnmol.2022.1024058","volume":"15","author":"RR Voskuhl","year":"2022","unstructured":"Voskuhl RR, MacKenzie-Graham A (2022) Chronic experimental autoimmune encephalomyelitis is an excellent model to study neuroaxonal degeneration in multiple sclerosis. Front Mol Neurosci 15:1024058","journal-title":"Front Mol Neurosci"},{"issue":"11","key":"4903_CR25","doi-asserted-by":"publisher","first-page":"a028977","DOI":"10.1101\/cshperspect.a028977","volume":"8","author":"S Glatigny","year":"2018","unstructured":"Glatigny S, Bettelli E (2018) Experimental autoimmune encephalomyelitis (EAE) as animal models of multiple sclerosis (MS). Cold Spring Harb Perspect Med 8(11):a028977","journal-title":"Cold Spring Harb Perspect Med"},{"key":"4903_CR26","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/BF02786446","volume":"17","author":"C Constantinescu","year":"1998","unstructured":"Constantinescu C, Milliard B, Fujioka T, Bhopale M, Calida D, Rostami A (1998) Pathogenesis of neuroimmunologic diseases: experimental models. Immunol Res 17:217\u2013227","journal-title":"Immunol Res"},{"issue":"1","key":"4903_CR27","doi-asserted-by":"crossref","first-page":"699","DOI":"10.22271\/phyto.2019.v8.i1z.15369","volume":"8","author":"D Singh","year":"2019","unstructured":"Singh D, Hembrom S, Raj A (2019) Neuroprotective effect of flavonoids: a systematic review. J Pharmacogn Phytochem 8(1):699\u2013707","journal-title":"J Pharmacogn Phytochem"},{"key":"4903_CR28","doi-asserted-by":"publisher","first-page":"1159806","DOI":"10.3389\/fnins.2023.1159806","volume":"17","author":"S Ranjan","year":"2023","unstructured":"Ranjan S, Gautam A (2023) Pharmaceutical prospects of silymarin for the treatment of neurological patients: an updated insight. Front Neurosci 17:1159806","journal-title":"Front Neurosci"},{"key":"4903_CR29","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.taap.2017.11.012","volume":"338","author":"M Kosari-Nasab","year":"2018","unstructured":"Kosari-Nasab M, Shokouhi G, Ghorbanihaghjo A, Abbasi MM, Salari A-A (2018) Anxiolytic-and antidepressant-like effects of Silymarin compared to diazepam and fluoxetine in a mouse model of mild traumatic brain injury. Toxicol Appl Pharmacol 338:159\u2013173","journal-title":"Toxicol Appl Pharmacol"},{"issue":"11","key":"4903_CR30","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1016\/j.freeradbiomed.2004.08.002","volume":"37","author":"KA Youdim","year":"2004","unstructured":"Youdim KA, Shukitt-Hale B, Joseph JA (2004) Flavonoids and the brain: interactions at the blood\u2013brain barrier and their physiological effects on the central nervous system. Free Radical Biol Med 37(11):1683\u20131693","journal-title":"Free Radical Biol Med"},{"key":"4903_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2008-2231-22-24","volume":"22","author":"P Yaghmaei","year":"2014","unstructured":"Yaghmaei P, Azarfar K, Dezfulian M, Ebrahim-Habibi A (2014) Silymarin effect on amyloid-\u03b2 plaque accumulation and gene expression of APP in an Alzheimer\u2019s disease rat model. DARU J Pharm Sci 22:1\u20137","journal-title":"DARU J Pharm Sci"},{"issue":"1\u20132","key":"4903_CR32","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jns.2011.07.035","volume":"309","author":"SS Raza","year":"2011","unstructured":"Raza SS, Khan MM, Ashafaq M, Ahmad A, Khuwaja G, Khan A, Siddiqui MS, Safhi MM et al (2011) Silymarin protects neurons from oxidative stress associated damages in focal cerebral ischemia: a behavioral, biochemical and immunohistological study in Wistar rats. J Neurol Sci 309(1\u20132):45\u201354","journal-title":"J Neurol Sci"},{"issue":"16","key":"4903_CR33","doi-asserted-by":"publisher","first-page":"5327","DOI":"10.3390\/molecules27165327","volume":"27","author":"K Wadhwa","year":"2022","unstructured":"Wadhwa K, Pahwa R, Kumar M, Kumar S, Sharma PC, Singh G, Verma R, Mittal V et al (2022) Mechanistic insights into the pharmacological significance of silymarin. Molecules 27(16):5327","journal-title":"Molecules"},{"issue":"2","key":"4903_CR34","first-page":"63","volume":"9","author":"T Radjabian","year":"2010","unstructured":"Radjabian T, Fallah HH (2010) Anti-hyperlipidemic and anti-atherosclerotic activities of silymarins from cultivated and wild plants of Silybum marianum L with different content of flavonolignans. Iran J Pharmacol Ther 9(2):63\u201367","journal-title":"Iran J Pharmacol Ther"},{"key":"4903_CR35","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1007\/s10753-019-00980-9","volume":"42","author":"M Shariati","year":"2019","unstructured":"Shariati M, Shaygannejad V, Abbasirad F, Hosseininasab F, Kazemi M, Mirmosayyeb O, Esmaeil N (2019) Silymarin restores regulatory T cells (tregs) function in multiple sclerosis (MS) patients in vitro. Inflammation 42:1203\u20131214","journal-title":"Inflammation"},{"key":"4903_CR36","doi-asserted-by":"publisher","first-page":"659678","DOI":"10.3389\/fneur.2021.659678","volume":"12","author":"H-L Yang","year":"2021","unstructured":"Yang H-L, Shi X-W (2021) Silybin alleviates experimental autoimmune encephalomyelitis by suppressing dendritic cell activation and Th17 cell differentiation. Front Neurol 12:659678","journal-title":"Front Neurol"},{"key":"4903_CR37","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s10753-018-0872-x","volume":"42","author":"F Navabi","year":"2019","unstructured":"Navabi F, Shaygannejad V, Abbasirad F, Vaez E, Hosseininasab F, Kazemi M, Mirmosayyeb O, Alsahebfosoul F et al (2019) Immunoregulatory effects of silymarin on proliferation and activation of Th1 cells isolated from newly diagnosed and IFN-\u00df 1b-treated MS patients. Inflammation 42:54\u201363","journal-title":"Inflammation"},{"issue":"20","key":"4903_CR38","doi-asserted-by":"publisher","first-page":"10130","DOI":"10.1073\/pnas.1821306116","volume":"116","author":"RR Voskuhl","year":"2019","unstructured":"Voskuhl RR, Itoh N, Tassoni A, Matsukawa MA, Ren E, Tse V, Jang E, Suen TT et al (2019) Gene expression in oligodendrocytes during remyelination reveals cholesterol homeostasis as a therapeutic target in multiple sclerosis. Proc Natl Acad Sci 116(20):10130\u201310139","journal-title":"Proc Natl Acad Sci"},{"issue":"11","key":"4903_CR39","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1111\/cns.12175","volume":"19","author":"A Borah","year":"2013","unstructured":"Borah A, Paul R, Choudhury S, Choudhury A, Bhuyan B, Das Talukdar A, Dutta Choudhury M, Mohanakumar KP (2013) Neuroprotective potential of silymarin against CNS disorders: insight into the pathways and molecular mechanisms of action. CNS Neurosci Ther 19(11):847\u2013853","journal-title":"CNS Neurosci Ther"},{"key":"4903_CR40","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.tox.2014.02.009","volume":"319","author":"J P\u00e9rez-H","year":"2014","unstructured":"P\u00e9rez-H J, Carrillo-S C, Garc\u00eda E, Ruiz-Mar G, P\u00e9rez-Tamayo R, Chavarr\u00eda A (2014) Neuroprotective effect of silymarin in a MPTP mouse model of Parkinson\u2019s disease. Toxicology 319:38\u201343","journal-title":"Toxicology"},{"key":"4903_CR41","doi-asserted-by":"publisher","first-page":"107685","DOI":"10.1016\/j.neuropharm.2019.107685","volume":"157","author":"M Zeraati","year":"2019","unstructured":"Zeraati M, Enayati M, Kafami L, Shahidi SH, Salari A-A (2019) Gut microbiota depletion from early adolescence alters adult immunological and neurobehavioral responses in a mouse model of multiple sclerosis. Neuropharmacology 157:107685","journal-title":"Neuropharmacology"},{"issue":"1","key":"4903_CR42","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3390\/molecules21010055","volume":"21","author":"L Wang","year":"2015","unstructured":"Wang L, Rotter S, Ladurner A, Heiss EH, Oberlies NH, Dirsch VM, Atanasov AG (2015) Silymarin constituents enhance ABCA1 expression in THP-1 macrophages. Molecules 21(1):55","journal-title":"Molecules"},{"issue":"3","key":"4903_CR43","doi-asserted-by":"publisher","first-page":"56","DOI":"10.5316\/wjn.v3.i3.56","volume":"3","author":"C Takeuchi","year":"2013","unstructured":"Takeuchi C, Yamagata K, Takemiya T (2013) Variation in experimental autoimmune encephalomyelitis scores in a mouse model of multiple sclerosis. World J Neurol 3(3):56\u201361","journal-title":"World J Neurol"},{"issue":"2","key":"4903_CR44","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jneumeth.2012.06.015","volume":"209","author":"PC Monsma","year":"2012","unstructured":"Monsma PC, Brown A (2012) FluoroMyelin\u2122 Red is a bright, photostable and non-toxic fluorescent stain for live imaging of myelin. J Neurosci Methods 209(2):344\u2013350","journal-title":"J Neurosci Methods"},{"issue":"19","key":"4903_CR45","doi-asserted-by":"publisher","first-page":"6094","DOI":"10.1523\/JNEUROSCI.0686-09.2009","volume":"29","author":"G Saher","year":"2009","unstructured":"Saher G, Quintes S, M\u00f6bius W, Wehr MC, Kr\u00e4mer-Albers E-M, Br\u00fcgger B, Nave K-A (2009) Cholesterol regulates the endoplasmic reticulum exit of the major membrane protein P0 required for peripheral myelin compaction. J Neurosci 29(19):6094\u20136104","journal-title":"J Neurosci"},{"issue":"1","key":"4903_CR46","doi-asserted-by":"publisher","first-page":"14241","DOI":"10.1038\/ncomms14241","volume":"8","author":"SA Berghoff","year":"2017","unstructured":"Berghoff SA, Gerndt N, Winchenbach J, Stumpf SK, Hosang L, Odoardi F, Ruhwedel T, B\u00f6hler C et al (2017) Dietary cholesterol promotes repair of demyelinated lesions in the adult brain. Nat Commun 8(1):14241","journal-title":"Nat Commun"},{"issue":"10","key":"4903_CR47","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.3390\/cells9102290","volume":"9","author":"D Fresegna","year":"2020","unstructured":"Fresegna D, Bullitta S, Musella A, Rizzo FR, De Vito F, Guadalupi L, Caioli S, Balletta S et al (2020) Re-examining the role of TNF in MS pathogenesis and therapy. Cells 9(10):2290","journal-title":"Cells"},{"issue":"2","key":"4903_CR48","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S1359-6101(98)00009-4","volume":"9","author":"JJ Lafaille","year":"1998","unstructured":"Lafaille JJ (1998) The role of helper T cell subsets in autoimmune diseases. Cytokine Growth Factor Rev 9(2):139\u2013151","journal-title":"Cytokine Growth Factor Rev"},{"issue":"3","key":"4903_CR49","first-page":"223","volume":"8","author":"P Kidd","year":"2003","unstructured":"Kidd P (2003) Th1\/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern Med Rev 8(3):223\u2013246","journal-title":"Altern Med Rev"},{"key":"4903_CR50","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/s10787-017-0407-3","volume":"26","author":"Z Zhu","year":"2018","unstructured":"Zhu Z, Sun G (2018) Silymarin mitigates lung impairments in a rat model of acute respiratory distress syndrome. Inflammopharmacology 26:747\u2013754","journal-title":"Inflammopharmacology"},{"issue":"12","key":"4903_CR51","doi-asserted-by":"publisher","first-page":"6774","DOI":"10.1007\/s12035-023-03485-7","volume":"60","author":"RJ Ram\u00edrez-Carreto","year":"2023","unstructured":"Ram\u00edrez-Carreto RJ, Zald\u00edvar-Machorro VJ, P\u00e9rez-Ram\u00edrez DJ, Rodr\u00edguez-L\u00f3pez BE, Meza C, Garc\u00eda E, Santamar\u00eda A, Chavarr\u00eda A (2023) Oral administration of silybin protects against MPTP-induced neurotoxicity by reducing pro-inflammatory cytokines and preserving BDNF levels in mice. Mol Neurobiol 60(12):6774\u20136788","journal-title":"Mol Neurobiol"},{"issue":"10","key":"4903_CR52","first-page":"1446","volume":"24","author":"M Azadpour","year":"2021","unstructured":"Azadpour M, Farajollahi MM, Dariushnejad H, Varzi AM, Varezardi A, Barati M (2021) Effects of synthetic silymarin-PLGA nanoparticles on M2 polarization and inflammatory cytokines in LPS-treated murine peritoneal macrophages. Iran J Basic Med Sci 24(10):1446","journal-title":"Iran J Basic Med Sci"},{"issue":"1","key":"4903_CR53","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41593-020-00757-6","volume":"24","author":"SA Berghoff","year":"2021","unstructured":"Berghoff SA, Spieth L, Sun T, Hosang L, Schlaphoff L, Depp C, D\u00fcking T, Winchenbach J et al (2021) Microglia facilitate repair of demyelinated lesions via post-squalene sterol synthesis. Nat Neurosci 24(1):47\u201360","journal-title":"Nat Neurosci"},{"key":"4903_CR54","first-page":"47","volume":"21","author":"M Waiz","year":"2022","unstructured":"Waiz M, Alvi SS, Khan MS (2022) Potential dual inhibitors of PCSK-9 and HMG-R from natural sources in cardiovascular risk management. EXCLI J 21:47","journal-title":"EXCLI J"},{"key":"4903_CR55","doi-asserted-by":"publisher","first-page":"924551","DOI":"10.3389\/fcvm.2022.924551","volume":"9","author":"P-L Liang","year":"2022","unstructured":"Liang P-L, Liang Q-W, He P-W, Chen X-L, Xu Y, Tu H-S, Zhang L, Qiu X-H et al (2022) Three polymethoxyflavones from the peel of Citrus reticulata \u201cChachi\u201d inhibits oxidized low-density lipoprotein-induced macrophage-derived foam cell formation. Front Cardiovasc Med 9:924551","journal-title":"Front Cardiovasc Med"},{"key":"4903_CR56","doi-asserted-by":"publisher","first-page":"105941","DOI":"10.1016\/j.jff.2023.105941","volume":"112","author":"K-X Hao","year":"2024","unstructured":"Hao K-X, Shen C-Y, Zhong R-F, Jiang J-G (2024) Multiple bioactivities of choerospondin obtained from blossom of Citrus aurantium L. Var. Amara engl. And its anti-inflammation and anti-atherosclerosis action pathways. J Funct Foods 112:105941","journal-title":"J Funct Foods"},{"issue":"2","key":"4903_CR57","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/FJC.0000000000000944","volume":"77","author":"Z-W Zhao","year":"2021","unstructured":"Zhao Z-W, Zhang M, Wang G, Zou J, Gao J-H, Zhou L, Wan X-J, Zhang D-W et al (2021) Astragalin retards atherosclerosis by promoting cholesterol efflux and inhibiting the inflammatory response via upregulating ABCA1 and ABCG1 expression in macrophages. J Cardiovasc Pharmacol 77(2):217\u2013227","journal-title":"J Cardiovasc Pharmacol"},{"issue":"3","key":"4903_CR58","doi-asserted-by":"publisher","first-page":"5216","DOI":"10.1080\/21655979.2022.2037374","volume":"13","author":"G Jiang","year":"2022","unstructured":"Jiang G, Sun C, Wang X, Mei J, Li C, Zhan H, Liao Y, Zhu Y et al (2022) Hepatoprotective mechanism of Silybum marianum on nonalcoholic fatty liver disease based on network pharmacology and experimental verification. Bioengineered 13(3):5216\u20135235","journal-title":"Bioengineered"},{"issue":"2","key":"4903_CR59","doi-asserted-by":"publisher","first-page":"E302","DOI":"10.1073\/pnas.1716032115","volume":"115","author":"N Itoh","year":"2018","unstructured":"Itoh N, Itoh Y, Tassoni A, Ren E, Kaito M, Ohno A, Ao Y, Farkhondeh V et al (2018) Cell-specific and region-specific transcriptomics in the multiple sclerosis model: Focus on astrocytes. Proc Natl Acad Sci 115(2):E302\u2013E309","journal-title":"Proc Natl Acad Sci"},{"key":"4903_CR60","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.nbd.2013.04.009","volume":"56","author":"J Wei","year":"2013","unstructured":"Wei J, Zheng M, Liang P, Wei Y, Yin X, Tang Y, Xue Y (2013) Apolipoprotein E and its mimetic peptide suppress Th1 and Th17 responses in experimental autoimmune encephalomyelitis. Neurobiol Dis 56:59\u201365","journal-title":"Neurobiol Dis"},{"key":"4903_CR61","doi-asserted-by":"publisher","first-page":"109372","DOI":"10.1016\/j.neuropharm.2022.109372","volume":"224","author":"S Liu","year":"2023","unstructured":"Liu S, Yang S, Zhou X, Zhu X, Xu L, Li X, Gao Z, Sun T et al (2023) Nerve injury-induced upregulation of apolipoprotein E in dorsal root ganglion participates in neuropathic pain in male mice. Neuropharmacology 224:109372","journal-title":"Neuropharmacology"},{"issue":"4","key":"4903_CR62","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1073\/pnas.83.4.1125","volume":"83","author":"MJ Ignatius","year":"1986","unstructured":"Ignatius MJ, Gebicke-H\u00e4rter PJ, Skene J, Schilling JW, Weisgraber KH, Mahley RW, Shooter EM (1986) Expression of apolipoprotein E during nerve degeneration and regeneration. Proc Natl Acad Sci 83(4):1125\u20131129","journal-title":"Proc Natl Acad Sci"},{"key":"4903_CR63","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0079-6123(08)61822-1","volume":"71","author":"MJ Ignatius","year":"1987","unstructured":"Ignatius MJ, Gebicke-Haerter PJ, Pitas RE, Shooter EM (1987) Apolipoprotein E in nerve injury and repair. Prog Brain Res 71:177\u2013184","journal-title":"Prog Brain Res"},{"issue":"1","key":"4903_CR64","doi-asserted-by":"publisher","first-page":"2702","DOI":"10.1038\/s41598-017-02638-8","volume":"7","author":"I Lavrnja","year":"2017","unstructured":"Lavrnja I, Smiljanic K, Savic D, Mladenovic-Djordjevic A, Tesovic K, Kanazir S, Pekovic S (2017) Expression profiles of cholesterol metabolism-related genes are altered during development of experimental autoimmune encephalomyelitis in the rat spinal cord. Sci Rep 7(1):2702","journal-title":"Sci Rep"},{"key":"4903_CR65","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1007\/s12031-014-0291-x","volume":"54","author":"M Zheng","year":"2014","unstructured":"Zheng M, Wei J, Tang Y, Yang C, Wei Y, Yin X, Liu Q (2014) ApoE-deficient promotes blood\u2013brain barrier disruption in experimental autoimmune encephalomyelitis via alteration of MMP-9. J Mol Neurosci 54:282\u2013290","journal-title":"J Mol Neurosci"},{"key":"4903_CR66","doi-asserted-by":"publisher","first-page":"104724","DOI":"10.1016\/j.nbd.2019.104724","volume":"136","author":"SA Flowers","year":"2020","unstructured":"Flowers SA, Rebeck GW (2020) APOE in the normal brain. Neurobiol Dis 136:104724","journal-title":"Neurobiol Dis"},{"key":"4903_CR67","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3389\/fncel.2018.00142","volume":"12","author":"X Yang","year":"2018","unstructured":"Yang X, Chen S, Shao Z, Li Y, Wu H, Li X, Mao L, Zhou Z, Bai L, Mei X (2018) Apolipoprotein E deficiency exacerbates spinal cord injury in mice: inflammatory response and oxidative stress mediated by NF-\u03baB signaling pathway. Front Cell Neurosci 12:142","journal-title":"Front Cell Neurosci"},{"issue":"6","key":"4903_CR68","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1111\/j.1471-4159.1991.tb03469.x","volume":"56","author":"JF Goodrum","year":"1991","unstructured":"Goodrum JF (1991) Cholesterol from degenerating nerve myelin becomes associated with lipoproteins containing apolipoprotein E. J Neurochem 56(6):2082\u20132086","journal-title":"J Neurochem"},{"issue":"4","key":"4903_CR69","doi-asserted-by":"publisher","first-page":"555","DOI":"10.2217\/clp.10.37","volume":"51","author":"DA Elliott","year":"2010","unstructured":"Elliott DA, Weickert CS, Garner B (2010) Apolipoproteins in the brain: implications for neurological and psychiatric disorders. Clin Lipidol 51(4):555","journal-title":"Clin Lipidol"},{"issue":"39","key":"4903_CR70","doi-asserted-by":"publisher","first-page":"40987","DOI":"10.1074\/jbc.M407963200","volume":"279","author":"SE Wahrle","year":"2004","unstructured":"Wahrle SE, Jiang H, Parsadanian M, Legleiter J, Han X, Fryer JD, Kowalewski T, Holtzman DM (2004) ABCA1 is required for normal central nervous system ApoE levels and for lipidation of astrocyte-secreted apoE. J Biol Chem 279(39):40987\u201340993","journal-title":"J Biol Chem"},{"issue":"39","key":"4903_CR71","doi-asserted-by":"publisher","first-page":"41197","DOI":"10.1074\/jbc.M407962200","volume":"279","author":"V Hirsch-Reinshagen","year":"2004","unstructured":"Hirsch-Reinshagen V, Zhou S, Burgess BL, Bernier L, McIsaac SA, Chan JY, Tansley GH et al (2004) Deficiency of ABCA1 impairs apolipoprotein E metabolism in brain. J Biol Chem 279(39):41197\u201341207","journal-title":"J Biol Chem"},{"issue":"10","key":"4903_CR72","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1002\/glia.24052","volume":"69","author":"E Nutma","year":"2021","unstructured":"Nutma E, Gebro E, Marzin MC, van der Valk P, Matthews PM, Owen DR, Amor S (2021) Activated microglia do not increase 18 kDa translocator protein (TSPO) expression in the multiple sclerosis brain. Glia 69(10):2447\u20132458","journal-title":"Glia"},{"issue":"8","key":"4903_CR73","first-page":"462","volume":"17","author":"H Wood","year":"2021","unstructured":"Wood H (2021) TSPO levels in multiple sclerosis lesions reflect microglial density rather than activation state. Nat Rev Neurol 17(8):462\u2013462","journal-title":"Nat Rev Neurol"},{"issue":"5","key":"4903_CR74","doi-asserted-by":"publisher","first-page":"e200133","DOI":"10.1212\/NXI.0000000000200133","volume":"10","author":"E Polvinen","year":"2023","unstructured":"Polvinen E, Matilainen M, Nylund M, Sucksdorff M, Airas LM (2023) TSPO-detectable chronic active lesions predict disease progression in multiple sclerosis. Neurol-Neuroimmunol Neuroinflamm 10(5):e200133","journal-title":"Neurol-Neuroimmunol Neuroinflamm"},{"issue":"1","key":"4903_CR75","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/ana.410050105","volume":"5","author":"J Prineas","year":"1979","unstructured":"Prineas J, Connell F (1979) Remyelination in multiple sclerosis. Ann Neurol: Off J Am Neurol Assoc Child Neurol Soc 5(1):22\u201331","journal-title":"Ann Neurol: Off J Am Neurol Assoc Child Neurol Soc"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-04903-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-04903-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-04903-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T12:19:07Z","timestamp":1757161147000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-04903-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,7]]},"references-count":75,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["4903"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-04903-8","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,7]]},"assertion":[{"value":"9 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experiments were conducted in compliance with the National Institutes of Health (NIH) guidelines for the Care and Use of Laboratory Animals and approved by the Committee of Ethics in Research at Tarbiat Modares University, Tehran, Iran (Ethical Approval ID: IR. MODARES. REC. 1399.225).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}